Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two ...
Morningstar6d
Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
We believe an effective antiviral agent for bird flu needs to potently suppress native and resistant viruses and ... small molecule CAP-dependent endonuclease inhibitor designed to be administered ...
Medical Xpress13d
Older adults might be more resistant to bird flu infections than children, research finds
Older adults who were exposed to seasonal flu viruses that circulated prior to 1968 were found to be more likely to have antibodies that bind to the H5N1 avian flu virus. The findings, published ...
Daily Record10d
One age group may be more resistant to bird flu, according to new research
New research has revealed that a certain age group may be more likely to possess antibodies that bind to bird flu. The study found that prior exposure to specific types of seasonal influenza ...
Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent ...